Global Banking and Finance Review is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website. .
Dollar stalls as dovish Fed and China hopes help euro By Harry Robertson and Tom Westbrook LONDON/SINGAPORE (Reuters) – The dollar stalled and the euro ticked...
Bank of England warns that some global asset valuations appear stretched By David Milliken and Huw Jones LONDON (Reuters) -The Bank of England said on Tuesday...
GSK signs shingles vaccine deal with China’s Zhifei for around $3 billion By Maggie Fick and Andrew Silver LONDON/SHANGHAI (Reuters) – China’s largest vaccines company Zhifei...
Progress in reforming development banks ‘quite limited,’ new tool shows By Andrea Shalal MARRAKECH, Morocco (Reuters) – A new tool launched on Monday to track reforms...
European shares decline at start of quarter’s last week on China woes By Bansari Mayur Kamdar (Reuters) -European shares fell at the start of the quarter’s...
Dollar steady as week of key central bank decisions kicks off By Saqib Iqbal Ahmed NEW YORK (Reuters) -The U.S. dollar held steady against a basket...
SoftBank’s Arm valued at $54.5 billion in year’s biggest IPO By Echo Wang and Anirban Sen NEW YORK (Reuters) – Chip designer Arm Holdings Plc secured...
European shares fall as weak China, euro zone data dents appetite By Sruthi Shankar and Shashwat Chauhan (Reuters) -European shares fell on Tuesday as weak services...
SoftBank’s Arm aims for over $52 billion valuation in biggest US IPO of the year By Manya Saini (Reuters) -SoftBank Group’s Arm is seeking a valuation...
World shares rally as China offers markets a hand By Nell Mackenzie and Amanda Cooper LONDON (Reuters) -U.S. stocks were set to open higher on Monday...
Dollar set for fifth winning week on Fed bets, China worries By Kevin Buckland TOKYO (Reuters) – The dollar was set for a fifth winning week...